Concepts (267)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostaglandin D2 | 16 | 2022 | 26 | 4.560 |
Why?
|
| Proteasome Endopeptidase Complex | 30 | 2023 | 116 | 4.240 |
Why?
|
| Neurons | 26 | 2019 | 1263 | 3.340 |
Why?
|
| Alzheimer Disease | 14 | 2025 | 1001 | 3.270 |
Why?
|
| Ubiquitin | 10 | 2013 | 81 | 2.280 |
Why?
|
| Encephalitis | 7 | 2018 | 43 | 1.820 |
Why?
|
| Cysteine Endopeptidases | 14 | 2004 | 64 | 1.750 |
Why?
|
| Multienzyme Complexes | 13 | 2004 | 69 | 1.610 |
Why?
|
| tau Proteins | 6 | 2017 | 186 | 1.510 |
Why?
|
| Neurodegenerative Diseases | 9 | 2022 | 141 | 1.440 |
Why?
|
| Rats | 22 | 2025 | 3735 | 1.240 |
Why?
|
| Calpain | 4 | 2019 | 35 | 1.110 |
Why?
|
| Ubiquitinated Proteins | 3 | 2013 | 6 | 1.090 |
Why?
|
| Hippocampus | 4 | 2025 | 594 | 1.070 |
Why?
|
| Animals | 46 | 2025 | 16992 | 1.000 |
Why?
|
| Ubiquitins | 13 | 2023 | 47 | 0.970 |
Why?
|
| Rats, Transgenic | 6 | 2025 | 34 | 0.960 |
Why?
|
| Disease Models, Animal | 10 | 2025 | 1596 | 0.930 |
Why?
|
| Signal Transduction | 9 | 2025 | 2157 | 0.930 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 5 | 2019 | 17 | 0.920 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2025 | 46 | 0.860 |
Why?
|
| Substantia Nigra | 2 | 2018 | 52 | 0.860 |
Why?
|
| Neurofibrillary Tangles | 4 | 2010 | 115 | 0.850 |
Why?
|
| Mitochondria | 3 | 2019 | 523 | 0.840 |
Why?
|
| Chalcones | 1 | 2024 | 17 | 0.830 |
Why?
|
| Membrane Proteins | 3 | 2025 | 561 | 0.780 |
Why?
|
| Cerebral Cortex | 5 | 2019 | 306 | 0.770 |
Why?
|
| Proteins | 6 | 2010 | 382 | 0.770 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2017 | 57 | 0.750 |
Why?
|
| Cyclic AMP | 2 | 2013 | 127 | 0.750 |
Why?
|
| Rats, Inbred F344 | 4 | 2025 | 258 | 0.690 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2017 | 35 | 0.650 |
Why?
|
| Amyloid beta-Protein Precursor | 3 | 2022 | 95 | 0.640 |
Why?
|
| Inflammation | 8 | 2023 | 758 | 0.630 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 35 | 0.590 |
Why?
|
| Ubiquitination | 2 | 2017 | 62 | 0.580 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 41 | 0.560 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 91 | 0.550 |
Why?
|
| Nerve Tissue Proteins | 5 | 2005 | 386 | 0.550 |
Why?
|
| Microglia | 3 | 2019 | 208 | 0.520 |
Why?
|
| Nerve Degeneration | 3 | 2009 | 111 | 0.520 |
Why?
|
| Pyrrolidines | 1 | 2017 | 31 | 0.510 |
Why?
|
| Caspases | 3 | 2017 | 148 | 0.510 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2017 | 38 | 0.500 |
Why?
|
| Pyrroles | 1 | 2017 | 72 | 0.500 |
Why?
|
| Brain | 1 | 2025 | 1472 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 1766 | 0.490 |
Why?
|
| Calcium | 1 | 2019 | 491 | 0.480 |
Why?
|
| Chymotrypsin | 6 | 2011 | 14 | 0.470 |
Why?
|
| Parkinson Disease | 2 | 2016 | 210 | 0.470 |
Why?
|
| Oxidative Stress | 5 | 2006 | 1003 | 0.450 |
Why?
|
| Dinoprostone | 4 | 2022 | 64 | 0.440 |
Why?
|
| Parkinsonian Disorders | 2 | 2018 | 42 | 0.440 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 4 | 0.430 |
Why?
|
| Mice | 17 | 2023 | 6644 | 0.420 |
Why?
|
| Oligopeptides | 4 | 2019 | 109 | 0.420 |
Why?
|
| Cadmium | 4 | 2004 | 56 | 0.410 |
Why?
|
| Autophagy | 2 | 2012 | 140 | 0.400 |
Why?
|
| Protein Multimerization | 2 | 2011 | 115 | 0.390 |
Why?
|
| Pituitary Gland | 5 | 1996 | 60 | 0.390 |
Why?
|
| Cyclic CMP | 1 | 2012 | 1 | 0.380 |
Why?
|
| Spinal Cord | 1 | 2012 | 114 | 0.360 |
Why?
|
| Aging | 2 | 2007 | 783 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2011 | 213 | 0.350 |
Why?
|
| Male | 12 | 2025 | 23409 | 0.350 |
Why?
|
| Inclusion Bodies | 4 | 2009 | 34 | 0.340 |
Why?
|
| Inflammation Mediators | 2 | 2009 | 140 | 0.330 |
Why?
|
| Isoenzymes | 2 | 2002 | 168 | 0.330 |
Why?
|
| Neurogenic Inflammation | 1 | 2010 | 2 | 0.320 |
Why?
|
| Receptors, Prostaglandin | 2 | 2022 | 7 | 0.310 |
Why?
|
| Prostaglandins | 2 | 2022 | 23 | 0.310 |
Why?
|
| Cathepsins | 1 | 2009 | 9 | 0.300 |
Why?
|
| Cell Line, Tumor | 8 | 2011 | 2676 | 0.300 |
Why?
|
| Female | 12 | 2025 | 24698 | 0.300 |
Why?
|
| Neuroblastoma | 3 | 2006 | 136 | 0.300 |
Why?
|
| Cells, Cultured | 6 | 2017 | 1621 | 0.280 |
Why?
|
| Enzyme Inhibitors | 4 | 2007 | 458 | 0.270 |
Why?
|
| Dopamine | 2 | 2009 | 275 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 5 | 2017 | 508 | 0.270 |
Why?
|
| Embryo, Mammalian | 3 | 2019 | 157 | 0.270 |
Why?
|
| Cysteine Proteinase Inhibitors | 2 | 2000 | 22 | 0.260 |
Why?
|
| Protease Inhibitors | 4 | 2011 | 54 | 0.250 |
Why?
|
| Endoplasmic Reticulum | 3 | 2006 | 108 | 0.250 |
Why?
|
| Enzyme Activation | 5 | 2012 | 462 | 0.250 |
Why?
|
| Humans | 22 | 2022 | 43102 | 0.240 |
Why?
|
| Phosphorylation | 4 | 2019 | 986 | 0.240 |
Why?
|
| Cytoskeleton | 1 | 2006 | 114 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2017 | 1124 | 0.240 |
Why?
|
| Drosophila melanogaster | 1 | 2007 | 193 | 0.230 |
Why?
|
| Mesencephalon | 3 | 2019 | 49 | 0.220 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2004 | 105 | 0.220 |
Why?
|
| Diazoxide | 1 | 2024 | 5 | 0.210 |
Why?
|
| Cell Death | 3 | 2012 | 278 | 0.210 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 135 | 0.210 |
Why?
|
| Up-Regulation | 2 | 2005 | 536 | 0.200 |
Why?
|
| Memory Disorders | 2 | 2023 | 77 | 0.200 |
Why?
|
| Cell Survival | 4 | 2012 | 945 | 0.190 |
Why?
|
| Peptide Fragments | 3 | 2007 | 307 | 0.190 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 73 | 0.180 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2002 | 28 | 0.180 |
Why?
|
| Protein Binding | 3 | 2016 | 1082 | 0.180 |
Why?
|
| Blotting, Western | 4 | 2011 | 883 | 0.180 |
Why?
|
| Acetylcysteine | 1 | 2002 | 57 | 0.180 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 146 | 0.180 |
Why?
|
| Kinetics | 6 | 2006 | 695 | 0.180 |
Why?
|
| Sulfonamides | 1 | 2002 | 91 | 0.170 |
Why?
|
| Cell Extracts | 2 | 2011 | 16 | 0.170 |
Why?
|
| Protein Structure, Quaternary | 2 | 2011 | 69 | 0.170 |
Why?
|
| Antineoplastic Agents | 3 | 2018 | 1019 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 968 | 0.160 |
Why?
|
| Cell Line | 6 | 2007 | 1410 | 0.160 |
Why?
|
| Leupeptins | 3 | 1999 | 12 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 185 | 0.150 |
Why?
|
| Oligomycins | 1 | 2019 | 2 | 0.150 |
Why?
|
| Antimycin A | 1 | 2019 | 5 | 0.150 |
Why?
|
| Calcimycin | 1 | 2019 | 11 | 0.150 |
Why?
|
| Okadaic Acid | 1 | 2019 | 16 | 0.150 |
Why?
|
| Time Factors | 3 | 2011 | 1857 | 0.150 |
Why?
|
| Rotenone | 1 | 2019 | 17 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 1999 | 48 | 0.150 |
Why?
|
| Gene Expression Regulation | 2 | 2019 | 1070 | 0.150 |
Why?
|
| Endopeptidases | 1 | 1999 | 64 | 0.150 |
Why?
|
| Creatinine | 1 | 2019 | 102 | 0.150 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2018 | 33 | 0.140 |
Why?
|
| Ibuprofen | 1 | 2018 | 34 | 0.140 |
Why?
|
| Dipeptides | 2 | 1999 | 31 | 0.140 |
Why?
|
| Exploratory Behavior | 1 | 2018 | 78 | 0.140 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2018 | 92 | 0.140 |
Why?
|
| Functional Laterality | 1 | 2018 | 89 | 0.140 |
Why?
|
| Sulfhydryl Compounds | 1 | 1998 | 51 | 0.140 |
Why?
|
| Cyclooxygenase 2 | 3 | 2004 | 107 | 0.140 |
Why?
|
| Aclarubicin | 2 | 1999 | 2 | 0.140 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2011 | 197 | 0.130 |
Why?
|
| Protein Subunits | 2 | 2011 | 93 | 0.130 |
Why?
|
| alpha-Synuclein | 2 | 2009 | 61 | 0.130 |
Why?
|
| Glycosylation | 1 | 2017 | 113 | 0.130 |
Why?
|
| Psychomotor Performance | 1 | 2018 | 159 | 0.130 |
Why?
|
| Cytoplasm | 1 | 2017 | 154 | 0.130 |
Why?
|
| Electron Transport Complex I | 1 | 2017 | 29 | 0.130 |
Why?
|
| Cattle | 5 | 1996 | 498 | 0.120 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1996 | 51 | 0.120 |
Why?
|
| Hydrolysis | 2 | 2011 | 97 | 0.120 |
Why?
|
| Pregnancy | 2 | 2011 | 1772 | 0.110 |
Why?
|
| Lysosomes | 2 | 2009 | 86 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 1 | 2014 | 114 | 0.110 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 239 | 0.110 |
Why?
|
| Coumarins | 2 | 2011 | 45 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2006 | 652 | 0.100 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 93 | 0.100 |
Why?
|
| Substrate Specificity | 4 | 1995 | 219 | 0.100 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2013 | 33 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2013 | 55 | 0.100 |
Why?
|
| Enzyme Stability | 1 | 2013 | 34 | 0.100 |
Why?
|
| Glutathione | 3 | 1999 | 171 | 0.100 |
Why?
|
| DNA Primers | 2 | 2004 | 294 | 0.100 |
Why?
|
| Bucladesine | 1 | 2012 | 10 | 0.100 |
Why?
|
| Caspase 3 | 1 | 2013 | 227 | 0.090 |
Why?
|
| Cell Separation | 2 | 2011 | 94 | 0.090 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 74 | 0.090 |
Why?
|
| Pyrazoles | 2 | 2023 | 103 | 0.090 |
Why?
|
| Biological Assay | 1 | 2012 | 63 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2004 | 166 | 0.090 |
Why?
|
| Base Sequence | 2 | 2004 | 983 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2014 | 373 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 1995 | 1180 | 0.090 |
Why?
|
| Centrifugation | 1 | 2011 | 7 | 0.090 |
Why?
|
| Molecular Sequence Data | 4 | 1995 | 1542 | 0.080 |
Why?
|
| Glycerol | 1 | 2011 | 34 | 0.080 |
Why?
|
| Mitomycins | 1 | 2010 | 7 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 196 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2023 | 665 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 95 | 0.080 |
Why?
|
| DNA Adducts | 1 | 2010 | 37 | 0.080 |
Why?
|
| Protein Structure, Secondary | 1 | 2011 | 182 | 0.080 |
Why?
|
| Protein Transport | 1 | 2011 | 296 | 0.080 |
Why?
|
| Protein Kinases | 1 | 2010 | 100 | 0.080 |
Why?
|
| Movement Disorders | 1 | 2009 | 9 | 0.080 |
Why?
|
| Gliosis | 1 | 2009 | 25 | 0.080 |
Why?
|
| Microinjections | 1 | 2009 | 50 | 0.080 |
Why?
|
| Tauopathies | 1 | 2009 | 22 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2009 | 153 | 0.070 |
Why?
|
| Peptide Hydrolases | 2 | 1999 | 44 | 0.070 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 2 | 1999 | 51 | 0.070 |
Why?
|
| Molecular Structure | 2 | 2004 | 570 | 0.070 |
Why?
|
| Cytosol | 2 | 2007 | 97 | 0.070 |
Why?
|
| Cytochrome P-450 Enzyme System | 2 | 1999 | 98 | 0.070 |
Why?
|
| RNA Interference | 2 | 2010 | 247 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 220 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 934 | 0.060 |
Why?
|
| Transfection | 2 | 2007 | 532 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 95 | 0.060 |
Why?
|
| Cyclopentanes | 1 | 2006 | 26 | 0.060 |
Why?
|
| Centrosome | 1 | 2006 | 30 | 0.060 |
Why?
|
| Brain Damage, Chronic | 1 | 2006 | 5 | 0.060 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 206 | 0.060 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2006 | 18 | 0.060 |
Why?
|
| Catecholamines | 1 | 2006 | 45 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 164 | 0.060 |
Why?
|
| Microtubules | 1 | 2006 | 121 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 310 | 0.060 |
Why?
|
| Apoptosis | 2 | 2010 | 1568 | 0.050 |
Why?
|
| DNA Repair | 1 | 2006 | 198 | 0.050 |
Why?
|
| Catalysis | 2 | 1996 | 187 | 0.050 |
Why?
|
| Prostaglandins A | 1 | 2004 | 1 | 0.050 |
Why?
|
| Synucleins | 1 | 2004 | 7 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2004 | 57 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2004 | 92 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2006 | 456 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2005 | 172 | 0.050 |
Why?
|
| Indolizines | 1 | 2023 | 7 | 0.050 |
Why?
|
| Protein Conformation | 2 | 1995 | 416 | 0.050 |
Why?
|
| Presenilin-1 | 1 | 2022 | 28 | 0.050 |
Why?
|
| Oxidoreductases, N-Demethylating | 2 | 1999 | 6 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 65 | 0.050 |
Why?
|
| Binding Sites | 1 | 2004 | 671 | 0.050 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2002 | 27 | 0.050 |
Why?
|
| Reticulocytes | 2 | 1999 | 9 | 0.050 |
Why?
|
| Rabbits | 2 | 1999 | 278 | 0.040 |
Why?
|
| Gene Expression | 1 | 2004 | 701 | 0.040 |
Why?
|
| Cyclooxygenase 1 | 1 | 2000 | 13 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2000 | 52 | 0.040 |
Why?
|
| CHO Cells | 1 | 1999 | 123 | 0.040 |
Why?
|
| Muramidase | 1 | 1999 | 30 | 0.040 |
Why?
|
| Microsomes, Liver | 1 | 1999 | 75 | 0.040 |
Why?
|
| Endosomes | 1 | 1998 | 33 | 0.040 |
Why?
|
| Heme | 1 | 1999 | 72 | 0.040 |
Why?
|
| Aldehydes | 1 | 1999 | 70 | 0.040 |
Why?
|
| Cricetinae | 1 | 1999 | 241 | 0.040 |
Why?
|
| Antioxidants | 1 | 2002 | 443 | 0.040 |
Why?
|
| Hydrogen Peroxide | 1 | 1999 | 190 | 0.030 |
Why?
|
| Zinc | 1 | 1999 | 131 | 0.030 |
Why?
|
| Cadmium Compounds | 1 | 1997 | 7 | 0.030 |
Why?
|
| Sulfates | 1 | 1997 | 26 | 0.030 |
Why?
|
| Homeostasis | 1 | 1998 | 192 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2000 | 638 | 0.030 |
Why?
|
| Disulfides | 1 | 1997 | 95 | 0.030 |
Why?
|
| Liver | 1 | 1999 | 511 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 1998 | 532 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2000 | 1271 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1995 | 26 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1998 | 876 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 1869 | 0.030 |
Why?
|
| Chloromercuribenzoates | 1 | 1994 | 1 | 0.030 |
Why?
|
| p-Chloromercuribenzoic Acid | 1 | 1994 | 1 | 0.030 |
Why?
|
| Dithiothreitol | 1 | 1994 | 18 | 0.030 |
Why?
|
| Fluorescent Dyes | 1 | 1995 | 182 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1995 | 388 | 0.030 |
Why?
|
| Mutation | 1 | 1998 | 1177 | 0.030 |
Why?
|
| Models, Biological | 2 | 2012 | 712 | 0.030 |
Why?
|
| Biological Transport | 2 | 2007 | 204 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 506 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1994 | 465 | 0.020 |
Why?
|
| Mitomycin | 1 | 2010 | 13 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2010 | 154 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 2 | 1999 | 20 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 436 | 0.020 |
Why?
|
| DNA Damage | 1 | 2010 | 356 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2007 | 127 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 144 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 458 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 518 | 0.010 |
Why?
|
| Dicarbethoxydihydrocollidine | 1 | 1999 | 1 | 0.010 |
Why?
|
| Cytochrome P-450 CYP2B1 | 1 | 1999 | 1 | 0.010 |
Why?
|
| Brefeldin A | 1 | 1999 | 4 | 0.010 |
Why?
|
| Benzene Derivatives | 1 | 1999 | 3 | 0.010 |
Why?
|
| Mixed Function Oxygenases | 1 | 1999 | 31 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1999 | 150 | 0.010 |
Why?
|
Figueiredo-Pereira's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(267)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_